WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Events
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

WSGR Events

2.19.26

Navigating National Security Risks in Life Sciences
As geopolitical concerns create hurdles for cross-border collaboration in biotechnology and life sciences, maintaining visibility into evolving national security and trade requirements is critical for effective global partnering. Wilson Sonsini’s National Security and Trade team invites you to join a webinar exploring recent national security and trade law developments affecting life sciences companies, including how companies are navigating the resulting challenges.
Affiliated Programs

9.17.25

L Suite (TechGC) Biotech GC Kickoff Dinner in Boston
On September 17, 2025, The L Suite (TechGC) is hosting our first-ever Biotech GC Kickoff Dinner in Boston, an invite-only evening bringing together CLOs and General Counsels from across the biotech ecosystem. The L Suite biotech community grows quickly, and this dinner is a chance for Boston legal leaders to gather in one room with their closest peers to talk openly about the challenges and opportunities shaping Biotech GCs today. Over a 3-course meal, we’ll dig into a conversation on the topic, “Partnering During Challenging Times: Getting the Deal Done in a Buyer’s Market.”
Affiliated Programs

3.13.25

2025 Entrepreneur and Investor Life Sciences Summit (E&I Summit), presented by BioUtah
Wilson Sonsini is looking forward to the 2025 Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah Technology Licensing Office. Now in its 12th year, the E&I Summit convenes Utah’s life sciences leaders, entrepreneurs, and the investor community.
WSGR Events

6.13.24

Wilson Sonsini’s 31st Annual Medical Device & Digital Health Conference
Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.
Affiliated Programs

10.16.23

NextGen VC Forum – Boston
Curated by Wilson Sonsini's Michael Hostetler and Dan Koeppen, LaunchBio’s NextGen VC Forum is the premiere event for venture capital associates to expand their skills and expertise while growing their network. The half-day forum includes a networking breakfast, three one-hour sessions and lunch. Attendance at NextGen VC Forum is by invitation only.
WSGR Events

6.15.23

Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference
Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2022’s fundraising and deals, and how 2023 is shaping up along with partnering strategies in the current market.
Speaking Engagements

6.01.23

2023 Yale Innovation Summit: Expanding Impact: Arts, Biotech, Climate, Health, Technology
Farah Gerdes moderates the discussion "Hottest New Ideas in Oncology ". Panelists include Roy Herbst, Ensign Professor of Medicine, Deputy Director Yale Cancer Center, Assistant Dean for Translational Research; Teresa Bitetti, President of the Global Oncology Business Unit, Takeda; Fred Cohen, Chairman, Monograph Capital Partners; Uciane Scarlett, Principal, MPM Capital; Deborah Palestrant, Partner, Executive Chair, 4:59 Initiative at 5AM Ventures; Ezogelin Oflazoglu-Gruyters, Vice-President, Head of External R&D and Strategic Alliances, Oncology R&D, AstraZeneca.
WSGR Events

4.27.23

College for Clients Series: IP Protection and Commercialization
It is critical for companies to understand how to best manage and protect their intellectual property. To support our clients' in-house counsel, business development VPs, CTOs, CIOs, contracts administrators, and others involved in IP-related issues, Wilson Sonsini is hosting a webinar that will provide practical tips and materials on best practices for preserving value and protecting against risk throughout the life cycle of a company.
Affiliated Programs

4.19.23

Board Excellence in 2023 and Beyond
The importance of board diversity cannot be understated, since boards need to be reflective of their stakeholders in order for the company to make smart strategic decisions, innovate, and improve performance—resulting in a competitive advantage and enhanced company culture over time. Though countless companies are working hard to increase board diversity, only about 22 percent of board seats at publicly traded U.S. companies are currently held by women. Join Wilson Sonsini and Firstboard.io for an in-depth panel discussion about how Boards can be part of the success of a company.
WSGR Events

6.17.22

29th Annual Medical Device Conference
Wilson Sonsini Goodrich & Rosati is hosting its 29th Annual Medical Device Conference to address questions of critical importance to medical device companies today. Join medical device entrepreneurs, CEOs of venture-backed companies, and business development executives from large medtech companies, as well as angels, venture capitalists, and corporate investors, for a dynamic day of networking and presentations that can help you craft a winning strategy. The conference will kick off with a reception and dinner on Thursday, June 16, 2022.
WSGR Events

5.25.22

Startup Bootcamp for Entrepreneurs
Wilson Sonsini is pleased to partner with Biohive, BioUtah, and The University of Utah PIVOT Center to host a Startup Bootcamp for Entrepreneurs. This is an exclusive one-day program designed for those in the process of—or considering—starting a new venture. Join us for this unique event that will provide practical information on the most important legal and business issues facing today’s entrepreneurs.
WSGR Events

6.18.20

28th Annual Medical Device Conference
At Wilson Sonsini, we take a tremendous amount of pride in our broad range of industry conferences and programs, which are widely regarded as providing crucial, high-value opportunities for networking, business development, and knowledge-sharing. At the same time, our top priority is the health and safety of everyone involved in our events. As a result, in light of the current COVID-19 pandemic, we have made the difficult decision to cancel the 28th Annual Medical Device Conference, previously scheduled to take place in San Francisco on June 18-19, 2020.

The firm is currently evaluating the possibility of holding a scaled-back, virtual version of this year’s conference at a later date. This page will be updated with any new developments.

The cancellation of this year’s in-person event is not the outcome we had hoped for, but given our overall concern for your well-being, the current uncertainty around the end date for shelter-in-place orders, and our commitment to contributing to global, national, and local efforts to slow the spread of the virus, we believe this is the right decision.  
  • 1
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.